Advanced Wound Care. Designed
to Reduce Financial Risk
Advanced Wound Care
Designed to Reduce
Financial Risk
Cellution Biologics, CHUM Health, and Shoreline Medical Administration come together through the Elite Graft Program to combine advanced biologic wound care solutions with reimbursement expertise, clinical documentation review, and clawback protection.
From graft access and claims management to post-payment review support, the program helps healthcare providers navigate reimbursement complexities and focus on delivering quality patient care.
What Does This Partnership Mean?
Three Specialized Capabilities. One Coordinated Program.
What Does This Partnership Mean?
Three Specialized Capabilities. One Coordinated Program.
Advanced Wound Care
Access a portfolio of biologic allografts designed for chronic and complex wound management, supported by scientific evidence.
Reimbursement Expertise
Navigate reimbursement workflows with support for insurance verification, prior authorization, coding, documentation, claims management, and revenue cycle performance.
Clinical Record Review & Clawback Protection
Strengthen documentation readiness and manage post-payment reimbursement risks with clinical record review, audit support, and clawback protection, subject to applicable program terms.
Clinical innovation. Reimbursement expertise. Documentation review and financial-risk protection—all working together to support your practice
Explore Cellution Biologics Inc. Advanced Wound Care Portfolio
A growing portfolio of biologic allografts built for chronic and complex wound management - backed by scientific rigor, and now paired with CHUM Health's reimbursement expertise and Shoreline’s post-payment risk management
for a smoother path to patient access.
Dehydrated Human Amnion - Intermediate Layer - Chorion Membrane Allograft
Lyophilized Human Amnion - Intermediate Layer - Chorion Membrane Allograft
Clinical Excellence
Discover Cellution Biologics Inc.'s portfolio of advanced biologic wound care solutions, purpose-built for chronic and complex wounds. Supported by published literature and interim data from a multicenter randomized controlled trial (RCT). 78% reduction wound area reduction by week 10 with AmchoPlast.1
by Week 10 with AmchoPlast1
Discover Cellution Biologics Inc.'s portfolio of advanced biologic wound care solutions, purpose-built for chronic and complex wounds. Supported by published literature and interim data from a multicenter randomized controlled trial (RCT). 78% reduction wound area reduction by week 10 with AmchoPlast.1
Ready to Simplify Your Reimbursement Journey?
Discover how Cellution Biologics, CHUM Health, and Shoreline Medical Administration work together through the Elite Graft Program to support advanced wound care, reimbursement workflows, and post-payment risk management.
Claims & Appeals
Management
Strengthen Documentation
& Compliance
Improve Reimbursement
Accuracy
Accelerate Cash
Flow
Post-Payment Audit & Clawback Protection
CHUM Health
Shoreline Medical Administration
CHUM Health
Shoreline Medical Administration